Amy D. Harper

Pediatric Neurology | Neurology

1250 E Marshall St
Richmond, VA 23298

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Journal: Journal of neuromuscular diseases

Published: February 06, 2026

Does Timing Matter? A Clinical Trial of Supporting Play Exploration and Early Development Intervention (SPEEDI) for Infants Born Preterm in the First Months of Life.

Does Timing Matter? A Clinical Trial of Supporting Play Exploration and Early Development Intervention (SPEEDI) for Infants Born Preterm in the First Months of Life.

Journal: The Journal of pediatrics

Published: February 03, 2026

Poly(ADP-ribose) polymerase inhibitor maintenance therapy in ovarian cancer: a single-center retrospective study.

Poly(ADP-ribose) polymerase inhibitor maintenance therapy in ovarian cancer: a single-center retrospective study.

Journal: Frontiers in oncology

Published: December 19, 2025

Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.

Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.

Journal: Annals of clinical and translational neurology

Published: February 27, 2025

Geriatrics cognitive assessment and resource engagement day: Piloting an interdisciplinary outpatient cognitive care model.

Geriatrics cognitive assessment and resource engagement day: Piloting an interdisciplinary outpatient cognitive care model.

Journal: Geriatric nursing (New York, N.Y.)

Published: February 05, 2025

Task-based effective connectivity finds alterations in frontoparietal network in Duchenne muscular dystrophy.

Task-based effective connectivity finds alterations in frontoparietal network in Duchenne muscular dystrophy.

Journal: Brain communications

Published: December 11, 2024

Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians.

Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians.

Journal: Annals of the Child Neurology Society

Published: May 08, 2024

Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.

Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.

Journal: Scientific reports

Published: April 16, 2024

Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.

Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.

Journal: Neurology

Published: February 09, 2024

Findings from the Longitudinal CINRG Becker Natural History Study.

Findings from the Longitudinal CINRG Becker Natural History Study.

Journal: Journal of neuromuscular diseases

Published: November 19, 2023

Impact of the COVID-19 Pandemic on a Clinical Trial: A Quantitative Report on Study Engagement and Strategies.

Impact of the COVID-19 Pandemic on a Clinical Trial: A Quantitative Report on Study Engagement and Strategies.

Journal: Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association

Published: July 25, 2023

Factors Influencing Receipt and Type of Therapy Services in the NICU.

Factors Influencing Receipt and Type of Therapy Services in the NICU.

Journal: Behavioral sciences (Basel, Switzerland)

Published: April 11, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026